There are 2789 resources available
310P - Substantial reduction in the percentage of metastatic breast cancer (MBC) which is HER-2 positive (HER-2+) over two decades: Sequential cohort analysis from the 1000 patient HER-2 study
Presenter: Jose Javier Berenguer-pina
Session: ePoster Display
311P - A global survey of the management of carcinomatous meningitis (CM) in breast cancer patients
Presenter: Evangelia Razis
Session: ePoster Display
312P - Survival of breast cancer patients with brain metastases treated with radiotherapy in Ontario, Canada: A population-based study
Presenter: Rania Chehade
Session: ePoster Display
313P - Use of PARPi among patients with advanced breast cancer
Presenter: Shaheenah Dawood
Session: ePoster Display
314P - Efficacy of taxane rechallenge in early metastatic relapse of HER2-negative breast cancer patients previously treated with taxane
Presenter: Antoine Vasseur
Session: ePoster Display
315P - Treatment patterns in black and indigenous people and people of color (BIPOC) receiving palbociclib for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in a real-world setting: POLARIS study results
Presenter: Gabrielle Rocque
Session: ePoster Display
316P - Attitudes towards the use of stereotactic body radiation therapy in oligometastatic breast cancer: Results of an OncoAlert survey
Presenter: Petra Vukovic
Session: ePoster Display
317P - Survival analysis and prognostic factors in patients with metastatic breast cancer and oligometastatic disease
Presenter: Gema Marin Zafra
Session: ePoster Display
318P - Impact of right dose vs on-time chemotherapy on PFS in patients suffering from metastatic breast cancer
Presenter: Anudeep Padakanti
Session: ePoster Display
319P - A propensity score weighted study comparing two versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer
Presenter: Herve Bischoff
Session: ePoster Display